BAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Braskem SA (BAK) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's financial performance is deteriorating, analysts have downgraded the stock, and there are no positive trading signals or catalysts to support a bullish outlook. The stock is better suited for avoidance at this time.
The stock shows mixed technical signals. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is below zero and negatively expanding, indicating bearish momentum. RSI is neutral at 50.667, and the price is hovering near the pivot point of 3.788, suggesting no clear breakout or breakdown.
NULL identified. The stock lacks positive sentiment or event-driven catalysts.
Braskem has announced it will not make an interest payment on its 2032 notes, raising concerns about financial stability.
Analysts have downgraded the stock and lowered price targets due to valuation concerns and challenges in the petrochemicals market.
Financial performance has significantly deteriorated, with revenue, net income, EPS, and gross margin all showing sharp declines in Q3 2025.
In Q3 2025, Braskem's financials showed significant declines: Revenue dropped by -17.18% YoY, Net Income fell by -95.54% YoY, EPS decreased by -92.31% YoY, and Gross Margin dropped by -76.18% YoY. The company is facing severe financial challenges.
Analysts have a negative outlook on the stock. Citi downgraded Braskem to Sell from Neutral, citing valuation concerns and challenges in the petrochemicals market. BofA lowered its price target to $3.30 from $3.70 and maintains a Neutral rating, reflecting negative sentiment following recent regulatory developments in Brazil.
